关注
Hao Yin
Hao Yin
在 whu.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
Non-viral vectors for gene-based therapy
H Yin, RL Kanasty, AA Eltoukhy, AJ Vegas, JR Dorkin, DG Anderson
Nature reviews genetics 15 (8), 541-555, 2014
33112014
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
H Yin, W Xue, S Chen, RL Bogorad, E Benedetti, M Grompe, ...
Nature biotechnology 32 (6), 551-553, 2014
12082014
Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
H Yin, CQ Song, JR Dorkin, LJ Zhu, Y Li, Q Wu, A Park, J Yang, S Suresh, ...
Nature biotechnology 34 (3), 328-333, 2016
9542016
CRISPR-mediated direct mutation of cancer genes in the mouse liver
W Xue, S Chen, H Yin, T Tammela, T Papagiannakopoulos, NS Joshi, ...
Nature 514 (7522), 380-384, 2014
8772014
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
JE Dahlman, C Barnes, OF Khan, A Thiriot, S Jhunjunwala, TE Shaw, ...
Nature nanotechnology 9 (8), 648-655, 2014
6722014
Delivery technologies for genome editing
H Yin, KJ Kauffman, DG Anderson
Nature reviews Drug discovery 16 (6), 387-399, 2017
5782017
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Y Dong, KT Love, JR Dorkin, S Sirirungruang, Y Zhang, D Chen, ...
Proceedings of the National Academy of Sciences 111 (11), 3955-3960, 2014
5072014
Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
H Yin, CQ Song, S Suresh, Q Wu, S Walsh, LH Rhym, E Mintzer, ...
Nature biotechnology 35 (12), 1179-1187, 2017
4892017
Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
D Wang, H Mou, S Li, Y Li, S Hough, K Tran, J Li, H Yin, DG Anderson, ...
Human gene therapy 26 (7), 432-442, 2015
3982015
Partial DNA-guided Cas9 enables genome editing with reduced off-target activity
H Yin, CQ Song, S Suresh, SY Kwan, Q Wu, S Walsh, J Ding, RL Bogorad, ...
Nature chemical biology 14 (3), 311-316, 2018
2372018
Genome editing with mRNA encoding ZFN, TALEN, and Cas9
HX Zhang, Y Zhang, H Yin
Molecular Therapy 27 (4), 735-746, 2019
2332019
Role of hepatic resident and infiltrating macrophages in liver repair after acute injury
Q You, M Holt, H Yin, G Li, CJ Hu, C Ju
Biochemical Pharmacology 86 (6), 836-843, 2013
1992013
CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
H Mou, JL Smith, L Peng, H Yin, J Moore, XO Zhang, CQ Song, A Sheel, ...
Genome biology 18, 1-8, 2017
1932017
CRISPR–Cas: a tool for cancer research and therapeutics
H Yin, W Xue, DG Anderson
Nature reviews Clinical oncology 16 (5), 281-295, 2019
1842019
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery
CA Alabi, KT Love, G Sahay, H Yin, KM Luly, R Langer, DG Anderson
Proceedings of the National Academy of Sciences 110 (32), 12881-12886, 2013
1822013
Adenine base editing in an adult mouse model of tyrosinaemia
CQ Song, T Jiang, M Richter, LH Rhym, LW Koblan, MP Zafra, ...
Nature biomedical engineering 4 (1), 125-130, 2020
1672020
Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas
JM Fritz, MA Tennis, DJ Orlicky, H Yin, C Ju, EF Redente, KS Choo, ...
Frontiers in immunology 5, 587, 2014
1642014
Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a
S Lu, X Tong, Y Han, K Zhang, Y Zhang, Q Chen, J Duan, X Lei, M Huang, ...
Nature biomedical engineering 6 (3), 286-297, 2022
1402022
Precision cancer mouse models through genome editing with CRISPR-Cas9
H Mou, Z Kennedy, DG Anderson, H Yin, W Xue
Genome medicine 7, 1-11, 2015
1272015
Genome-wide CRISPR screen identifies regulators of mitogen-activated protein kinase as suppressors of liver tumors in mice
CQ Song, Y Li, H Mou, J Moore, A Park, Y Pomyen, S Hough, Z Kennedy, ...
Gastroenterology 152 (5), 1161-1173. e1, 2017
1232017
系统目前无法执行此操作,请稍后再试。
文章 1–20